Changing the paradigm of organ utilization from PHS increased-risk donors: An opportunity whose time has come?

Clinical Transplantation

Volumn 29, Issue 9, 2015, Pages 724-727

  Sibulesky, Lena ^a   Javed, Imran ^a   Reyes, Jorge D ^a   Limaye, Ajit P ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Increased risk organ donors; Kidney transplants; Liver transplant; Organ shortage; PHS donors

Indexed keywords

ARTICLE; DRUG USE; FALSE POSITIVE RESULT; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFORMED CONSENT; KIDNEY GRAFT; LIVER GRAFT; ORGAN DONOR; ORGAN TRANSPLANTATION; PATIENT EDUCATION; PRIORITY JOURNAL; PROSTITUTION; PUBLIC HEALTH SERVICE; VIRUS TRANSMISSION; DONOR; DONOR SELECTION; HEALTH CARE DELIVERY; PATIENT SAFETY; RISK ASSESSMENT; RISK FACTOR; STANDARDS; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; UNITED STATES;

DONOR SELECTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; ORGAN TRANSPLANTATION; PATIENT SAFETY; RISK ASSESSMENT; RISK FACTORS; TISSUE DONORS; UNITED STATES;

EID: 84940956320     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12582     Document Type: Article

References (16)

1. Sahulee R, Lytrivi ID, Savla JJ, Rossano JW. Centers for disease control "high-risk" donor status does not significantly affect recipient outcome after heart transplantation in children. J Heart Lung Transplant 2014: 33: 1173.
2. Seem DL, Lee I, Umscheid CA, Kuehnert MJ. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep 2013: 128: 247.
3. Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant 2009: 9: 629.
4. Ros RL, Kucirka LM, Govindan P, Sarathy H, Montgomery RA, Segev DL. Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups. Clin Transplant 2012: 26: 247.
5. Kim WR, Smith JM, Skeans MA et al. OPTN/SRTR 2012 annual data report: liver. Am J Transplant 2014: 14: 69.
6. Kucirka LM, Sarathy H, Govindan P et al. Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant 2011: 11: 1188.
7. Kucirka LM, Sarathy H, Govindan P et al. Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant 2011: 11: 1176.
8. Ison MG, Grossi P. Donor-derived infections in solid organ transplantation. Am J Transplant 2013: 13: 22.
9. Theodoropoulos N, Jaramillo A, Ladner DP, Ison MG. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices. Am J Transplant 2013: 13: 2186.
10. Humar A, Morris M, Blumberg E et al. Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant 2010: 10: 889.
11. Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Provider utilization of high-risk donor organs and nucleic acid testing: results of two national surveys. Am J Transplant 2009: 9: 1197.
12. Duan KI, Englesbe MJ, Volk ML. Centers for Disease Control 'High-Risk' donors and kidney utilization. Am J Transplant 2010: 10: 416.
13. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. Rockville, MD: U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation.
14. Xu B, Lin L, Xu G et al. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 2015: 30: 372.
15. Deepak J, Massimo P, Ivana C, Kosh A. Recurrent HCV after liver transplantation-mechanisms, assessment and therapy. Nat Rev Gastroenterol Hepatol 2014: 11: 710.
16. Stock PG, Barin B, Murphy B et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010: 18: 2004.